Published in
Wiley, European Journal of Heart Failure, 8(22), p. 1462-1471, 2020
DOI: 10.1002/ejhf.1860
Links
Tools
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease ( AMBER ): results in the pre‐specified subgroup with heart failure
Journal article published in 2020 by
Patrick Rossignol,
Bryan Williams 
,
Martha R. Mayo,
Suzette Warren,
Susan Arthur,
Gail Ackourey,
William B. White,
Rajiv Agarwal
,
Martha R. Mayo,
Suzette Warren,
Susan Arthur,
Gail Ackourey,
William B. White,
Rajiv Agarwal
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 